Scarica l'app Stockscreener
34.49
2.10%
0.71
Pre-mercato:
34.49
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARWR Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$33.78
Aprire:
$33.88
Volume 24 ore:
2.53M
Relative Volume:
1.06
Capitalizzazione di mercato:
$4.77B
Reddito:
$181.74M
Utile/perdita netta:
$-143.97M
Rapporto P/E:
-24.81
EPS:
-1.39
Flusso di cassa netto:
$9.60M
1 W Prestazione:
+6.12%
1M Prestazione:
+56.56%
6M Prestazione:
+170.72%
1 anno Prestazione:
+78.06%
Intervallo 1D:
$33.55
$34.61
Intervallo di 1 settimana:
$31.45
$34.61
Portata 52W:
$9.57
$34.61
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
Nome
Arrowhead Pharmaceuticals Inc
Settore
Industria
Telefono
626-696-4702
Indirizzo
177 E COLORADO BLVD, PASADENA, CA
Confronta ARWR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARWR
Arrowhead Pharmaceuticals Inc
|
34.49 | 4.67B | 181.74M | -143.97M | 9.60M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-05 | Iniziato | Goldman | Neutral |
| 2023-12-04 | Iniziato | BofA Securities | Buy |
| 2023-09-19 | Iniziato | Citigroup | Neutral |
| 2023-07-21 | Iniziato | TD Cowen | Outperform |
| 2023-05-12 | Downgrade | SVB Securities | Outperform → Market Perform |
| 2023-04-26 | Iniziato | SMBC Nikko | Outperform |
| 2023-04-12 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2023-03-21 | Iniziato | Bernstein | Mkt Perform |
| 2022-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-11 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-01-19 | Ripresa | Goldman | Buy |
| 2021-08-06 | Reiterato | Chardan Capital Markets | Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Neutral |
| 2021-02-05 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-11-19 | Iniziato | Citigroup | Buy |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-05-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-04-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-03-24 | Aggiornamento | SVB Leerink | Underperform → Mkt Perform |
| 2020-03-17 | Iniziato | Goldman | Neutral |
| 2020-01-21 | Iniziato | SVB Leerink | Underperform |
| 2019-12-13 | Iniziato | Oppenheimer | Perform |
| 2019-11-29 | Reiterato | Chardan Capital Markets | Buy |
| 2019-11-27 | Reiterato | B. Riley FBR | Buy |
| 2019-11-25 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-10-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-10-22 | Reiterato | Chardan Capital Markets | Buy |
| 2019-10-03 | Iniziato | Robert W. Baird | Outperform |
| 2018-09-07 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-09-06 | Reiterato | Chardan Capital Markets | Buy |
| 2018-08-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-07-02 | Reiterato | Chardan Capital Markets | Buy |
Mostra tutto
Arrowhead Pharmaceuticals Inc Borsa (ARWR) Ultime notizie
Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Intrinsic Value Is Potentially 72% Above Its Share Price - Yahoo Finance
Arrowhead Pharmaceuticals stock hits 52-week high at 34.53 USD By Investing.com - Investing.com Australia
Arrowhead Pharmaceuticals stock hits 52-week high at 34.53 USD - Investing.com India
Can Quantum Digital Vision India Ltd Beat EPS Estimates in the Next QuarterDividend Stability Analysis & Stay Safe With Built-In Risk Monitoring - earlytimes.in
Arrowhead and Sarepta close $500 million licensing deal - MSN
Ranking Arrowhead Pharmaceuticals Inc. among high performing stocks via toolsWeekly Risk Report & Consistent Income Trade Recommendations - newser.com
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 1-Year HighWhat's Next? - MarketBeat
13,500 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Acquired by Moody Lynn & Lieberson LLC - MarketBeat
Can Arrowhead Pharmaceuticals Inc. stock deliver surprise earnings beat2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
What technical models suggest about Arrowhead Pharmaceuticals Inc.’s comebackWeekly Trend Recap & Consistent Profit Alerts - newser.com
Arrowhead Pharmaceuticals Inc. (ARWR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why millennials buy Arrowhead Pharmaceuticals Inc. (HDP1) stockJuly 2025 Highlights & AI Forecast Swing Trade Picks - newser.com
4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals - inkl
Is Arrowhead Pharmaceuticals Inc a good long term investmentEarnings Forecast Updates & Free Significant Capital Appreciation - earlytimes.in
Will Arrowhead Pharmaceuticals Inc. (HDP1) stock outperform small cap peersJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com
What analysts say about Arrowhead Pharmaceuticals Inc stockGap Up/Gap Down Analysis & Free Rapid Portfolio Appreciation - earlytimes.in
Is Arrowhead Pharmaceuticals Inc HDP1 a good long term investmentEarnings Miss Alerts & Capital Allocation Recommendations - earlytimes.in
Arrowhead Pharmaceuticals, Inc. $ARWR Stock Position Decreased by Voya Investment Management LLC - MarketBeat
Will Arrowhead Pharmaceuticals Inc. stock outperform Dow Jones index2025 Support & Resistance & Growth Focused Stock Pick Reports - newser.com
Arrowhead Pharmaceuticals Hits New 52-Week High of $33.73 - Markets Mojo
Arrowhead Pharmaceuticals Hits New 52-Week High at $33.00 - Markets Mojo
Arrowhead Pharmaceuticals Hits New 52-Week High at $32.17 - Markets Mojo
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 52-Week HighWhat's Next? - MarketBeat
Piper Sandler Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $45 - 富途牛牛
H.C. Wainwright Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Arrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 1-Year HighStill a Buy? - MarketBeat
Arrowhead Pharmaceuticals Hits New 52-Week High at $31.67 - Markets Mojo
Arrowhead Pharmaceuticals stock hits 52-week high at 31.7 USD By Investing.com - Investing.com Canada
Arrowhead Pharmaceuticals stock hits 52-week high at 31.7 USD - Investing.com
What is HC Wainwright's Estimate for ARWR FY2025 Earnings? - MarketBeat
Arrowhead Pharmaceuticals Hits New 52-Week High at $31.62 - Markets Mojo
Arrowhead Pharmaceuticals Hits Day High with 8.17% Surge in Stock Price - Markets Mojo
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives $43.14 Average PT from Analysts - MarketBeat
Published on: 2025-09-21 07:04:10 - خودرو بانک
Market Recap: What is UBERs revenue forecastQuarterly Growth Report & Smart Investment Allocation Insights - khodrobank.com
Breakouts Watch: Can Arrowhead Pharmaceuticals Inc maintain its current growth ratePortfolio Update Report & Long-Term Investment Growth Plans - khodrobank.com
Aug Rallies: Is GIFI a top pick in the sectorQuarterly Profit Review & Daily Momentum Trading Reports - khodrobank.com
Rhumbline Advisers Has $4.41 Million Holdings in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat
James C. Hamilton Sells 15,000 Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock - MarketBeat
Volume Summary: Whats next for BlackRock Health Sciences Trust stockMarket Sentiment Report & Weekly Chart Analysis and Guides - khodrobank.com
Big Picture: Whats the beta of Arrowhead Pharmaceuticals Inc stock2025 Price Momentum & Free High Accuracy Swing Entry Alerts - خودرو بانک
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 2,774,933 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat
Aug Outlook: Is Arrowhead Pharmaceuticals Inc stock a top performer YTDQuarterly Market Summary & Real-Time Buy Zone Alerts - khodrobank.com
Trading Action: What are Arrowhead Pharmaceuticals Incs recent SEC filings showingWatch List & Free Weekly Watchlist of Top Performers - خودرو بانک
What’s the fair value of Xeris Biopharma Holdings Inc. stockMarket Weekly Review & Capital Protection Trading Alerts - khodrobank.com
Analyst Downgrade: Is Imperial Petroleum Inc stock forming a triangle patternWeekly Stock Report & Long Hold Capital Preservation Tips - khodrobank.com
Earnings Report: Is Arrowhead Pharmaceuticals Inc forming a bullish divergence2025 Geopolitical Influence & Comprehensive Market Scan Reports - خودرو بانک
Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Woodline Partners LP - MarketBeat
Treasury Yields: Will Satellogic Inc Equity Warrant stock benefit from M A2025 Retail Activity & Daily Profit Maximizing Trade Tips - خودرو بانک
Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue - MSN
Arrowhead Pharmaceuticals Inc Azioni (ARWR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):